Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Mar 28, 2024
Date Accepted: Apr 8, 2025

The final, peer-reviewed published version of this preprint can be found here:

Developing a Core Outcome Set for Pediatric and Adult Acute and Chronic Pain Extended Reality Trials: Delphi Consensus-Building Process

Hess C, Logan DE, Rosenbloom BN, Mesaroli G, Simons LE, Ouellette C, Nguyen C, Alam F, Stinson JN

Developing a Core Outcome Set for Pediatric and Adult Acute and Chronic Pain Extended Reality Trials: Delphi Consensus-Building Process

J Med Internet Res 2025;27:e58947

DOI: 10.2196/58947

PMID: 40408138

PMCID: 12144474

Core outcome set for pediatric and adult acute and chronic pain extended reality trials: Results from multi-step consensus building process

  • Courtney Hess; 
  • Deirdre E Logan; 
  • Brittany N Rosenbloom; 
  • Giulia Mesaroli; 
  • Laura E Simons; 
  • Carley Ouellette; 
  • Cynthia Nguyen; 
  • Fahad Alam; 
  • Jennifer N Stinson

ABSTRACT

Background:

Appropriate outcome assessment strategies and high-quality trials are critical to advancing care of pediatric and adult patients in acute and chronic pain using extended reality (XR). XR, namely virtual and augmented reality (VR and AR), as a nonpharmacological treatment for pain has accelerated in the last decade. VR transposes the user to an alternative real or computer-generated environment, while AR enhances an existing physical environment with additional virtual objects embedded in that real setting. XR allows users to engage completely in immersive, gamified, and interactive digital experiences. To date, no standardized approach to assessing outcomes of XR-based interventions for pain exists.

Objective:

Our aim was to recommend a core set of outcome measures for pediatric and adult acute and chronic pain XR intervention trials.

Methods:

In the first phase we conducted two systematic reviews on XR in acute and chronic pain trials in (1) pediatrics and (2) adults, respectively, to identify the most common core outcome domains assessed. These data then informed the second phase, a Delphi survey of clinicians and researchers using XR for pain treatment. In the third phase, a two day in person meeting was held to reach consensus on recommended outcome domains for adult and pediatric acute and chronic pain XR clinical trials. This was followed by a second round of the Delphi survey to broaden consensus.

Results:

By unanimous vote, pain severity, adverse events, user experience, and psychological constructs were identified as mandatory domains to be assessed in all trials for acute and chronic pain, with the addition of pain interference for chronic pain trials. Physiological markers and physical function were deemed important to consider but optional domains. Additional emerging areas for future research did not obtain sufficient support in the consensus process but were noted.

Conclusions:

Future work is underway to provide recommendations for appropriate validated measures to assess each established outcome domain.


 Citation

Please cite as:

Hess C, Logan DE, Rosenbloom BN, Mesaroli G, Simons LE, Ouellette C, Nguyen C, Alam F, Stinson JN

Developing a Core Outcome Set for Pediatric and Adult Acute and Chronic Pain Extended Reality Trials: Delphi Consensus-Building Process

J Med Internet Res 2025;27:e58947

DOI: 10.2196/58947

PMID: 40408138

PMCID: 12144474

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.